Precision BioSciences (DTIL) Receives a Rating Update from a Top Analyst
at www.tipranks.com (Thu, 8-Jan 7:06 AM)
DTIL Showcases Promising First-in-Class Hepatitis B Gene Editing Data: Global Clinical Expansion Announced
Market Chameleon (Wed, 19-Nov 9:14 AM)
